000 | 01916 a2200541 4500 | ||
---|---|---|---|
005 | 20250517222246.0 | ||
264 | 0 | _c20190501 | |
008 | 201905s 0 0 eng d | ||
022 | _a1432-1084 | ||
024 | 7 |
_a10.1007/s00330-018-5454-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFroelich, Matthias F | |
245 | 0 | 0 |
_aCT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. _h[electronic resource] |
260 |
_bEuropean radiology _cDec 2018 |
||
300 |
_a5284-5292 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aColorectal Neoplasms _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGermany _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aSurvival Rate _xtrends |
650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
700 | 1 | _aHeinemann, Volker | |
700 | 1 | _aSommer, Wieland H | |
700 | 1 | _aHolch, Julian W | |
700 | 1 | _aSchoeppe, Franziska | |
700 | 1 | _aHesse, Nina | |
700 | 1 | _aBaumann, Alena B | |
700 | 1 | _aKunz, Wolfgang G | |
700 | 1 | _aReiser, Maximilian F | |
700 | 1 | _aRicke, Jens | |
700 | 1 | _aD'Anastasi, Melvin | |
700 | 1 | _aStintzing, Sebastian | |
700 | 1 | _aModest, Dominik P | |
700 | 1 | _aKazmierczak, Philipp M | |
700 | 1 | _aHofmann, Felix O | |
773 | 0 |
_tEuropean radiology _gvol. 28 _gno. 12 _gp. 5284-5292 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00330-018-5454-7 _zAvailable from publisher's website |
999 |
_c28510224 _d28510224 |